180 related articles for article (PubMed ID: 32801201)
1. Association between plasma exosome neurogranin and brain structure in patients with Alzheimer's disease: a protocol study.
He M; Sun L; Cao W; Yin C; Sun W; Liu P; Tan L; Xu Z; Zhao W
BMJ Open; 2020 Aug; 10(8):e036990. PubMed ID: 32801201
[TBL] [Abstract][Full Text] [Related]
2. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
[TBL] [Abstract][Full Text] [Related]
3. MRI-based comparative study of different mild cognitive impairment subtypes: protocol for an observational case-control study.
Yu Y; Zhao W; Li S; Yin C
BMJ Open; 2017 Mar; 7(3):e013432. PubMed ID: 28274963
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
[TBL] [Abstract][Full Text] [Related]
5. Ageing stereotypes and prodromal Alzheimer's disease (AGING): study protocol for an ongoing randomised clinical study.
Gauthier K; Morand A; Dutheil F; Alescio-Lautier B; Boucraut J; Clarys D; Eustache F; Girard N; Guedj E; Mazerolle M; Paccalin M; de la Sayette V; Zaréa A; Huguet P; Michel BF; Desgranges B; ; Régner I
BMJ Open; 2019 Oct; 9(10):e032265. PubMed ID: 31594904
[TBL] [Abstract][Full Text] [Related]
6. Sino Longitudinal Study on Cognitive Decline (SILCODE): protocol for a Chinese longitudinal observational study to develop risk prediction models of conversion to mild cognitive impairment in individuals with subjective cognitive decline.
Li X; Wang X; Su L; Hu X; Han Y
BMJ Open; 2019 Jul; 9(7):e028188. PubMed ID: 31350244
[TBL] [Abstract][Full Text] [Related]
7. Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
Fu Z; Zhao M; Wang X; He Y; Tian Y; Yang Y; Han Y; Li S
J Alzheimers Dis; 2021; 79(3):1121-1132. PubMed ID: 33386805
[TBL] [Abstract][Full Text] [Related]
8. Blood neuro-exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage.
Jia L; Zhu M; Kong C; Pang Y; Zhang H; Qiu Q; Wei C; Tang Y; Wang Q; Li Y; Li T; Li F; Wang Q; Li Y; Wei Y; Jia J
Alzheimers Dement; 2021 Jan; 17(1):49-60. PubMed ID: 32776690
[TBL] [Abstract][Full Text] [Related]
9. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
Tarawneh R; D'Angelo G; Crimmins D; Herries E; Griest T; Fagan AM; Zipfel GJ; Ladenson JH; Morris JC; Holtzman DM
JAMA Neurol; 2016 May; 73(5):561-71. PubMed ID: 27018940
[TBL] [Abstract][Full Text] [Related]
11. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
[TBL] [Abstract][Full Text] [Related]
12. Association of cerebrospinal fluid Neurogranin with Alzheimer's disease.
Wang L;
Aging Clin Exp Res; 2019 Feb; 31(2):185-191. PubMed ID: 29667155
[TBL] [Abstract][Full Text] [Related]
13. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.
Bos I; Vos S; Vandenberghe R; Scheltens P; Engelborghs S; Frisoni G; Molinuevo JL; Wallin A; Lleó A; Popp J; Martinez-Lage P; Baird A; Dobson R; Legido-Quigley C; Sleegers K; Van Broeckhoven C; Bertram L; Ten Kate M; Barkhof F; Zetterberg H; Lovestone S; Streffer J; Visser PJ
Alzheimers Res Ther; 2018 Jul; 10(1):64. PubMed ID: 29980228
[TBL] [Abstract][Full Text] [Related]
14. Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.
Sanfilippo C; Forlenza O; Zetterberg H; Blennow K
J Neural Transm (Vienna); 2016 Dec; 123(12):1443-1447. PubMed ID: 27531278
[TBL] [Abstract][Full Text] [Related]
15. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease.
Vipin A; Loke YM; Liu S; Hilal S; Shim HY; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J
Alzheimers Res Ther; 2018 Aug; 10(1):82. PubMed ID: 30121086
[TBL] [Abstract][Full Text] [Related]
16. Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.
Monacelli F; Borghi R; Cammarata S; Nencioni A; Piccini A; Tabaton M; Odetti P
J Alzheimers Dis; 2015; 45(1):89-95. PubMed ID: 25471189
[TBL] [Abstract][Full Text] [Related]
17. The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.
De Vos A; Struyfs H; Jacobs D; Fransen E; Klewansky T; De Roeck E; Robberecht C; Van Broeckhoven C; Duyckaerts C; Engelborghs S; Vanmechelen E
J Alzheimers Dis; 2016 Jul; 53(4):1523-38. PubMed ID: 27392859
[TBL] [Abstract][Full Text] [Related]
18. Tablet-based sensorimotor home-training system for amnestic mild cognitive impairments in the elderly: design of a randomised clinical trial.
Bekrater-Bodmann R; Löffler A; Silvoni S; Frölich L; Hausner L; Desch S; Kleinböhl D; Flor H
BMJ Open; 2019 Aug; 9(8):e028632. PubMed ID: 31377702
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
Kvartsberg H; Duits FH; Ingelsson M; Andreasen N; Öhrfelt A; Andersson K; Brinkmalm G; Lannfelt L; Minthon L; Hansson O; Andreasson U; Teunissen CE; Scheltens P; Van der Flier WM; Zetterberg H; Portelius E; Blennow K
Alzheimers Dement; 2015 Oct; 11(10):1180-90. PubMed ID: 25533203
[TBL] [Abstract][Full Text] [Related]
20. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
